Osaka City General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

    The European respiratory journal, Vol. 61, Núm. 2